Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AFRM vs GSK✓SelectedUSD · GSKAFRM vs GSK performance historyLatest closeAs of-3.69%11/16
Stock and ETF performance explorer

AFRM vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-34.9%
GSK return
+72.9%
Excess return
-107.9%
Maximum drawdown
-94.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.7%-0.1%-3.6%-3.7%
7D-7.8%-1.3%-6.5%-7.6%
30D-15.3%+2.7%-18.0%-15.7%
3M-20.0%+2.7%-22.7%-20.4%
6M-4.7%+3.3%-8.1%-5.7%
YTD-15.7%+6.5%-22.2%-17.7%
1Y-11.1%+10.7%-21.7%-13.9%
3Y+155.5%+64.4%+91.2%+110.2%
5Y-58.5%+46.7%-105.2%-65.5%
All-34.9%+72.9%-107.9%-48.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling